Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Drivers
DGX logo

Quest Diagnostics Revenues Climb 13.1% to $2.816 Billion Amid Acquisition Gains

DGX10-QFiling Date: 10/21/2025
Quest Diagnostics Incorporated
Description

What this story covers

Quest Diagnostics' Q3 2025 10-Q shows 13.1% revenue growth to $2.816B, driven by diagnostics and acquisitions. Operating income rose 16.9% to $386M via efficiencies. Strong cash flow supports dividends, buybacks, and cost savings. Risks include reimbursement pressures and regulations.

Story snapshot

CompanyQuest Diagnostics Incorporated
TickerDGX
VariantStandard detailed
Duration9:53
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001022079-25-000218

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in